Nitric oxide signaling connects the three systems, regulating blood flow and inflammatory responses across muscular, digestive, and neural tissue simultaneously
If a question comes up and you say no to BPC-157, write down your reasoning and that discussion too
Generally well-tolerated in research settings Mild nausea with higher doses Injection site redness or discomfort Rare: Dizziness or lightheadedness Potential effect on blood pressure (monitor if hypertensive) BPC-157 (Oral) is banned from 503A compounding pharmacies
BPC-157 is notably stable in gastric acid, unusual for a peptide
Tirzepatide (Mounjaro, Zepbound) Dual GLP-1 & GIP receptor agonist for enhanced weight loss and fat metabolism
The study also found that 99.2% of patients achieved at least 5% weight loss, 93.9% lost 10% or more, and nearly half (47.8%) achieved 20% or more body weight loss